Nxstage Medical, Inc. (NXTM) Misses Q2 EPS by 1c; Boosts FY14 Revs Outlook
Tweet
Share
E-mailGet Alerts NXTM Hot Sheet
Price: $30.00 --0%
Financial Fact:
Provision for income taxes: 324K
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Provision for income taxes: 324K
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Nxstage Medical, Inc. (NASDAQ: NXTM) reported Q2 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $74.1 million versus the consensus estimate of $70.52 million.
Nxstage Medical sees FY2014 revenue of $290 - $293 million, versus the consensus of $288.08 million.
For earnings history and earnings-related data on Nxstage Medical, Inc. (NXTM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Valens Semiconductor (VLN) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
